Fluorescent dye to check tumor margins during surgery
Part of Cancer clinical trials.
This Phase 2 study tests whether using a fluorescent dye during tumor surgery can help the surgical team better see where the tumor ends. It may help aim for complete removal and lower the chance of the tumor coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older with a first-time (not previously removed) bone or soft-tissue tumor planned for surgical removal by an orthopaedic cancer specialist.
- Your tumor was confirmed by biopsy, and it has a meaningful risk of coming back locally or elsewhere.
- Your surgeon explains the operation and you already gave consent for the surgery before research consent.
- You are not pregnant and not breastfeeding.
- You have no known severe allergic reaction to contrast dye or fluorescein (a fluorescent dye).
- Your kidneys are healthy enough for the study; you are not on dialysis and do not have kidney failure or uremia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special dye and imaging technique to help surgeons see and remove sarcoma tumors more completely. The goal is to reduce the chance that cancer cells are accidentally left behind during surgery.
This trial tests a special dye that helps surgeons see the edges of sarcoma tumors during surgery. It may help them remove all the cancer while saving healthy tissue.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
This study uses a special dye that makes tumors glow during surgery, helping your surgeon see exactly what to remove and what to leave. It aims to make surgery more precise and safer for people with bone or soft tissue tumors.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This trial tests whether a fluorescent dye applied to tissue during surgery helps doctors see tumors and check if the tumor removal is complete. If you have a solid tumor and are scheduled for surgery, this study may improve the precision of your operation.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.